Dr. Anil Bhan cardiothoracic surgery at Medanta Hospital Gurgaontoday introduced that the triclip™ transcatheter tricuspid valve repair system has acquired CE mark and is now accredited to be used in India as a non-surgical treatment for people suffering from a leaky tricuspid valve, a condition known as tricuspid regurgitation (TR). This device is the first minimally invasive, clip-based tricuspid valve repair device to be commercially available in the world.

The tricuspid valve often called the "forgotten heart valve," has 3 leaflets that manage the glide of blood among the 2 chambers at the right side of the heart. Whilst those leaflets do not close properly, blood can flow in the opposite direction – referred to as regurgitation – forcing the heart to work more difficult. Whilst left untreated, TR can result in conditions including atrial fibrillation, coronary heart failure, and in the long run, death. The condition is hard to deal with, but, and options for patients have historically been extremely limited. People with TR are generally older and be afflicted by more than one co-morbidities, making open-coronary heart surgical treatment an excessive-risky method.

The TriClip process repairs the tricuspid valve without open-heart surgery. The device is brought to the heart through the femoral vein in the leg and works with the aid of clipping collectively a portion of the leaflets of the tricuspid valve to lessen the backflow of blood. This technique permits the heart to pump blood greater effectively, relieving signs of TR and improving a person's quality of life.

"Patients suffering from intense tricuspid regurgitation are extremely unwell and response to very few treatment options," stated Dr. Anil Bhan cardiothoracic surgery at Medanta hospital Gurgaon. "Abbott’sTriClip ought to profoundly affect how physicians treat those patients. The treatment is subsidized with the aid of records proving protection and overall performance, durability, and stepped forward person quality of life."

"Tricuspid regurgitation is noticeably prevalent, yet seldom dealt with ailment, which is why this approval is a significant milestone for the healthcare network. TriClip has the capability to fill a treatment hole and transform how doctors are able to help people with tricuspid regurgitation," stated Dr. Anil Bhan cardiothoracic surgery at Medanta hospital Gurgaon. "Our clip-based technology affords clinicians a life-converting, established safe, simple, and effective choice to deal with people suffering from a crippling and lifestyles-threatening disease."

According to Dr. Anil Bhan cardiothoracic surgery at Medanta hospital Gurgaon, “the MitraClip system is the first and best transcatheter mitral valve treatment with more than 16 years of medical experience and demonstrated safety, survival, and sturdy results. More than 100,000 patients had been treated international with the device.” Dr. Anil Bhan cardiothoracic surgery at Medanta Hospital Gurgaon recently introduced a Tendyne Transcatheter mitral valve implantation device, a minimally invasive valve alternative choice to add to its portfolio of mitral solutions.

India Cardiac Surgery Hospital

313/41-c, Old Rohtak Rd,

Inderlok, New Delhi,

Delhi 110035


[email protected]